TrialMedical oncology (Northwood, London, England)2017

A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy.

J Konmun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.